1Pietanza MC, Ladanyi M. Bringing the genomic landscape of small-cell lung cancer into focus. Nat Genet, 2012, 44(10): 1074-1075. 被引量：1
2Peifer M, Fernlindez-Cuesta L, Sos ML, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet, 2012, 44(10): 1104-1110. 被引量：1
3Meuwissen R, Linn SC, Linnoila RI, et al. Induction of smaU cell lung cancer by somatic inactivation of both Trp53 and Rbl in a conditional mouse modal. Cancer Cell, 2003, 4(3): 181-189. 被引量：1
4Rudin CM, Durinck S, Stawiski EW, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet, 2012, 44(10): 1111-1116. 被引量：1
5Iwakawa R, Takenaka M, Kohno T, et al. Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer. Genes Chromosomes Cancer, 2013, 52(9): 802-816. 被引量：1
6Byers LA, Wang J, Nilsson MB, et al. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP 1. Cancer Discov, 2012, 2(9): 798-811. 被引量：1
7Wistuba Ⅱ, Gazdar AF, Minna JD. Molecular genetics of small cell lung carcinoma. Semin Oncol, 2001, 28(Suppl 4): 3-13. 被引量：1
8Coe BP, Thu KL, Aviel-Ronen S, et al. Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer. PLoS One, 2013, 8(8): e71670. 被引量：1
9Zacharatos P, Kotsinas A, Evangelou K, et al. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. J Pathol, 2004, 203(3): 744-753. 被引量：1
10Vissers JH, van Lohuizen M, Citterio E. The emerging role of Polycomb repressors in the response to DNA damage. J Cell Sci, 2012, 125(17): 3939-3948. 被引量：1
